Cara Therapeutics
$22.129876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$22.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.78 (-3.40%) Today
-$0.04 (-0.18%) As of 4:26 PM EDT after-hours
Why Robinhood?
You can buy or sell CARA and other stocks, options, ETFs, and crypto commission-free!
About CARA
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. Read More The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
Employees
55
Headquarters
Stamford, Connecticut
Founded
2004
Market Cap
1.07B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
574.23K
High Today
$23.12
Low Today
$21.74
Open Price
$22.92
Volume
3.74M
52 Week High
$27.55
52 Week Low
$12.19
Collections
Price Paid on Robinhood
35% Higher
Right Now
52 Week Low
$11.50
Average Price Paid
$16.35
52 Week High
$24.30
Analyst Ratings
90%
of 10 ratings
Buy
90%
Hold
10%
Sell
0%
CARA Earnings
-$0.61
-$0.51
-$0.42
-$0.32
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 5, After Hours